Journal articles on the topic '(HIV-1)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic '(HIV-1).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Tsukada, Kunihisa. "1. HIV-1 Infection." Nihon Naika Gakkai Zasshi 96, no. 11 (2007): 2442–49. http://dx.doi.org/10.2169/naika.96.2442.
Full textAsang, Corinna, Hans-J. Laws, Ortwin Adams, Jürgen Enczmann, Cornelia Feiterna-Sperling, Gundula Notheis, Bernd Buchholz, Arndt Borkhardt, and Jennifer Neubert. "HIV-1 seroreversion in HIV-1-infected children." AIDS 28, no. 4 (February 2014): 543–47. http://dx.doi.org/10.1097/qad.0000000000000065.
Full textHansasuta, Pokrath, and Sarah L. Rowland-Jones. "HIV-1 transmission and acute HIV-1 infection." British Medical Bulletin 58, no. 1 (September 1, 2001): 109–27. http://dx.doi.org/10.1093/bmb/58.1.109.
Full textCurran, Kathryn, Jared M. Baeten, Thomas J. Coates, Ann Kurth, Nelly R. Mugo, and Connie Celum. "HIV-1 Prevention for HIV-1 Serodiscordant Couples." Current HIV/AIDS Reports 9, no. 2 (March 14, 2012): 160–70. http://dx.doi.org/10.1007/s11904-012-0114-z.
Full textLoussert-Ajaka, I., F. Brun-Vézinet, F. Simon, T. D. Ly, M. L. Chaix, S. Saragosti, A. M. Couroucé, and D. Ingrand. "HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients." Lancet 343, no. 8910 (June 1994): 1393–94. http://dx.doi.org/10.1016/s0140-6736(94)92524-0.
Full textFujiwara, Mamoru, and Masafumi Takiguchi. "HIV-1–specific CTLs effectively suppress replication of HIV-1 in HIV-1–infected macrophages." Blood 109, no. 11 (June 1, 2007): 4832–38. http://dx.doi.org/10.1182/blood-2006-07-037481.
Full textBradbury, Jane. "HIV-1-resistant individuals may lack HIV-1 coreceptor." Lancet 348, no. 9025 (August 1996): 463. http://dx.doi.org/10.1016/s0140-6736(05)64540-0.
Full textShen, R., M. Raska, D. Bimczok, J. Novak, and P. D. Smith. "HIV-1 Envelope Glycan Moieties Modulate HIV-1 Transmission." Journal of Virology 88, no. 24 (October 1, 2014): 14258–67. http://dx.doi.org/10.1128/jvi.02164-14.
Full textZeytinoğlu, Ayşın, Münevver Kayın, İmre Altuğlu, Deniz Gökengin, and Rüçhan Sertöz. "İki Anti-HIV Doğrulama Testinin Karşılaştırılması: Rekombinant HIV 1/2 “Line İmmunoassay” ve Geenius HIV 1/2 Doğrulama Testi." Mikrobiyoloji Bulteni 54, no. 4 (October 15, 2020): 613–18. http://dx.doi.org/10.5578/mb.69786.
Full textJoseph, J. Mehsen. "Testing (HIV-1)." Infection Control and Hospital Epidemiology 12, no. 8 (August 1991): 474–75. http://dx.doi.org/10.2307/30146877.
Full textFultz, Patricia N. "HIV-1 superinfections." AIDS 18, no. 1 (January 2004): 115–19. http://dx.doi.org/10.1097/00002030-200401020-00014.
Full textStevenson, Mario. "HIV-1 pathogenesis." Nature Medicine 9, no. 7 (July 2003): 853–60. http://dx.doi.org/10.1038/nm0703-853.
Full textJoseph, J. Mehsen. "Testing (HIV-1)." Infection Control and Hospital Epidemiology 12, no. 8 (August 1991): 474–75. http://dx.doi.org/10.1086/646385.
Full textWaters, Laura, and Erasmus Smit. "HIV-1 superinfection." Current Opinion in Infectious Diseases 25, no. 1 (February 2012): 42–50. http://dx.doi.org/10.1097/qco.0b013e32834ef5af.
Full textHarwig, Alex, Atze T. Das, and Ben Berkhout. "HIV-1 RNAs." Current Opinion in HIV and AIDS 10, no. 2 (March 2015): 103–9. http://dx.doi.org/10.1097/coh.0000000000000135.
Full textPomerantz, Roger J. "HIV-1 reservoirs." Clinics in Laboratory Medicine 22, no. 3 (September 2002): 651–80. http://dx.doi.org/10.1016/s0272-2712(02)00005-7.
Full textNakatani, Yoshihiro. "HIV-1 Transcription." Structure 10, no. 4 (April 2002): 443–44. http://dx.doi.org/10.1016/s0969-2126(02)00754-2.
Full textStrebel, Klaus. "HIV-1 Vpu." Molecular Cell 14, no. 2 (April 2004): 150–52. http://dx.doi.org/10.1016/s1097-2765(04)00205-9.
Full textAllen, Todd M., and Marcus Altfeld. "HIV-1 superinfection." Journal of Allergy and Clinical Immunology 112, no. 5 (November 2003): 829–35. http://dx.doi.org/10.1016/j.jaci.2003.08.037.
Full textMok, Jacqueline. "HIV-1 INFECTION." Lancet 341, no. 8850 (April 1993): 930–31. http://dx.doi.org/10.1016/0140-6736(93)91217-a.
Full textPodzorski, Raymond P. "HIV-1 genotyping." Reviews in Medical Microbiology 14, no. 1 (January 2003): 25–34. http://dx.doi.org/10.1097/00013542-200301000-00003.
Full textExcler, Jean-Louis, Merlin L. Robb, and Jerome H. Kim. "HIV-1 vaccines." Human Vaccines & Immunotherapeutics 10, no. 6 (March 17, 2014): 1734–46. http://dx.doi.org/10.4161/hv.28462.
Full textPanos, George, and Mark Nelson. "HIV-1 tropism." Biomarkers in Medicine 1, no. 4 (December 2007): 473–81. http://dx.doi.org/10.2217/17520363.1.4.473.
Full textVisan, Ioana. "Restricting HIV-1." Nature Immunology 14, no. 11 (October 21, 2013): 1117. http://dx.doi.org/10.1038/ni.2753.
Full textBuckland, Jenny. "Silencing HIV-1." Nature Reviews Immunology 2, no. 7 (July 2002): 458. http://dx.doi.org/10.1038/nri849.
Full textNAVE, J. "HIV-1 inhibitor." Drug Discovery Today 1, no. 4 (April 1996): 170. http://dx.doi.org/10.1016/1359-6446(96)89068-4.
Full textIwamoto, Aikichi, Noriaki Hosoya, and Ai Kawana-Tachikawa. "HIV-1 tropism." Protein & Cell 1, no. 6 (June 2010): 510–13. http://dx.doi.org/10.1007/s13238-010-0066-2.
Full text&NA;. "HIV-1 vaccine promising in children with HIV-1 infection." Inpharma Weekly &NA;, no. 1205 (September 1999): 10. http://dx.doi.org/10.2165/00128413-199912050-00016.
Full textGoto, Toshiyuki, Chizuko Morita, Taisuke Ashina, Kazuyoshi Ikuta, Shiro Kato, and Masuyo Nakal. "Localization of constituent proteins of HIV Type 1 (HIV-1)." Proceedings, annual meeting, Electron Microscopy Society of America 48, no. 3 (August 12, 1990): 340–41. http://dx.doi.org/10.1017/s0424820100159242.
Full textMaeda, Yosuke, Keisuke Yusa, and Shinji Harada. "Enhanced infectivity of HIV-1 by X4 HIV-1 coinfection." Biochemical and Biophysical Research Communications 308, no. 4 (September 2003): 906–13. http://dx.doi.org/10.1016/s0006-291x(03)01498-0.
Full textSuzuki, Shintaro, Emiko Urano, Chie Hashimoto, Hiroshi Tsutsumi, Toru Nakahara, Tomohiro Tanaka, Yuta Nakanishi, et al. "Peptide HIV-1 Integrase Inhibitors from HIV-1 Gene Products." Journal of Medicinal Chemistry 53, no. 14 (July 22, 2010): 5356–60. http://dx.doi.org/10.1021/jm1003528.
Full textReagan, KevinJ, CathyC Lile, Yair Devash, John Turner, Yu-Wen Hu, and C. Yong Kang. "Use of HIV-1 pol gene precursor to detect HIV-1 and HIV-2." Lancet 335, no. 8683 (January 1990): 236. http://dx.doi.org/10.1016/0140-6736(90)90338-6.
Full textMourez, Thomas, Constance Delaugerre, Muriel Vray, Véronique Lemée, François Simon, and Jean-Christophe Plantier. "Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants." Journal of Clinical Virology 71 (October 2015): 76–81. http://dx.doi.org/10.1016/j.jcv.2015.08.007.
Full textAraujo, Abelardo Q. C. "Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection." Pathogens 9, no. 4 (March 28, 2020): 250. http://dx.doi.org/10.3390/pathogens9040250.
Full text&NA;. "HIV-1 expression inhibited by HIV-2." Inpharma Weekly &NA;, no. 1021 (January 1996): 10. http://dx.doi.org/10.2165/00128413-199610210-00015.
Full textTravis, J. "HIV-2 Offers Protection against HIV-1." Science News 147, no. 24 (June 17, 1995): 373. http://dx.doi.org/10.2307/3978894.
Full textSavall, R., X. Balanzo, J. L. Fernandez, F. Valls, and V. Soriano. "HIV-1 and HIV-2 in Spain." Sexually Transmitted Infections 68, no. 2 (April 1, 1992): 143. http://dx.doi.org/10.1136/sti.68.2.143.
Full textHayes, R. J., P. G. Smith, François Denis, and Francis Barin. "SEROPOSITIVITY TO HIV-1 AND HIV-2." Lancet 329, no. 8543 (May 1987): 1199–200. http://dx.doi.org/10.1016/s0140-6736(87)92163-5.
Full textSarr, Abdoulaye Dieng, Donald J. Hamel, Ibou Thior, Efi Kokkotou, Jean-Louis Sankalé, Richard G. Marlink, Eva-Marie Coll-Seck, et al. "HIV-1 and HIV-2 dual infection." AIDS 12, no. 2 (January 1998): 131–37. http://dx.doi.org/10.1097/00002030-199802000-00002.
Full textWeiss, Robin A., Paul R. Clapham, Jonathan N. Weber, Denise Whitby, Richard S. Tedder, Tim OʼConnor, Sophie Chamaret, and Luc Montagnier. "HIV-2 antisera cross-neutralize HIV-1." AIDS 2, no. 2 (April 1988): 95–100. http://dx.doi.org/10.1097/00002030-198804000-00004.
Full textZanchetta, Marisa, Alessia Anselmi, Daniela Vendrame, Osvalda Rampon, Carlo Giaquinto, Antonio Mazza, Daniele Accapezzato, Vincenzo Barnaba, and Anita De Rossi. "Early Therapy in HIV-1-Infected Children: Effect on HIV-1 Dynamics and HIV-1-Specific Immune Response." Antiviral Therapy 13, no. 1 (January 2008): 47–56. http://dx.doi.org/10.1177/135965350801300105.
Full textMor, Orna, Yael Gozlan, Marina Wax, Fernando Mileguir, Avia Rakovsky, Bina Noy, Ella Mendelson, and Itzchak Levy. "Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load." Journal of Clinical Microbiology 53, no. 11 (August 19, 2015): 3458–65. http://dx.doi.org/10.1128/jcm.01806-15.
Full textOrtiz de Lejarazu, R., V. Soriano, J. M. Eiros, M. Arias, and C. Toro. "HIV-1 Infection in Persistently HIV-1-Seronegative Individuals: More Reasons for HIV RNA Screening." Clinical Infectious Diseases 46, no. 5 (March 1, 2008): 785. http://dx.doi.org/10.1086/527569.
Full textHønge, BL, S. Jespersen, C. Medina, DS Té, ZJ da Silva, M. Christiansen, B. Kjerulff, et al. "The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections." HIV Medicine 19, no. 6 (March 24, 2018): 403–10. http://dx.doi.org/10.1111/hiv.12606.
Full textTorresilla, Cynthia, Jean-Michel Mesnard, and Benoit Barbeau. "Reviving an Old HIV-1 Gene: The HIV-1 Antisense Protein." Current HIV Research 13, no. 2 (April 15, 2015): 117–24. http://dx.doi.org/10.2174/1570162x12666141202125943.
Full textLi, Hailong, Kristen A. McLaurin, Jessica M. Illenberger, Charles F. Mactutus, and Rosemarie M. Booze. "Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders." Viruses 13, no. 5 (May 17, 2021): 924. http://dx.doi.org/10.3390/v13050924.
Full textDimitrakopoulos, Antonios N. "Mixed Cryoglobulinemia in HIV-1 Infection: The Role of HIV-1." Annals of Internal Medicine 130, no. 3 (February 2, 1999): 226. http://dx.doi.org/10.7326/0003-4819-130-3-199902020-00027.
Full textLevin, Judith G., Mithun Mitra, Anjali Mascarenhas, and Karin Musier-Forsyth. "Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription." RNA Biology 7, no. 6 (November 2010): 754–74. http://dx.doi.org/10.4161/rna.7.6.14115.
Full textCampbell, Edward M., and Thomas J. Hope. "HIV-1 capsid: the multifaceted key player in HIV-1 infection." Nature Reviews Microbiology 13, no. 8 (July 16, 2015): 471–83. http://dx.doi.org/10.1038/nrmicro3503.
Full textDiedrich, Collin R., and JoAnne L. Flynn. "HIV-1/Mycobacterium tuberculosisCoinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?" Infection and Immunity 79, no. 4 (January 18, 2011): 1407–17. http://dx.doi.org/10.1128/iai.01126-10.
Full text